1. Home
  2. KD vs PCVX Comparison

KD vs PCVX Comparison

Compare KD & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kyndryl Holdings Inc.

KD

Kyndryl Holdings Inc.

N/A

Current Price

$12.56

Market Cap

2.8B

Sector

Technology

ML Signal

N/A

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

N/A

Current Price

$56.25

Market Cap

6.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KD
PCVX
Founded
2020
2013
Country
United States
United States
Employees
80000
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
6.1B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
KD
PCVX
Price
$12.56
$56.25
Analyst Decision
Buy
Strong Buy
Analyst Count
5
7
Target Price
$35.25
$98.33
AVG Volume (30 Days)
5.2M
1.0M
Earning Date
05-11-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
170.95
N/A
EPS
0.77
N/A
Revenue
$15,057,000,000.00
N/A
Revenue This Year
$3.96
N/A
Revenue Next Year
$0.41
N/A
P/E Ratio
$16.44
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.10
$28.09
52 Week High
$43.74
$76.61

Technical Indicators

Market Signals
Indicator
KD
PCVX
Relative Strength Index (RSI) 35.11 48.83
Support Level $11.34 $42.30
Resistance Level $13.81 $57.50
Average True Range (ATR) 0.53 2.96
MACD 0.49 -0.68
Stochastic Oscillator 53.83 14.14

Price Performance

Historical Comparison
KD
PCVX

About KD Kyndryl Holdings Inc.

Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: